Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple tumor-related signaling pathways refer to a network of interconnected molecular cascades that regulate key processes in cancer, including cell proliferation, survival, metastasis, invasion, and drug resistance. These pathways are frequently dysregulated in malignant tumors and represent critical targets for therapeutic intervention. Key pathways include Wnt/β-catenin, PI3K/AKT/mTOR, MAPK, Notch, and NF-kB. Targeting single nodes often leads to limited efficacy due to compensatory mechanisms within the network, necessitating multi-targeted agents or combination therapies.
Inhibition of specific kinases or proteins within the signaling pathways to disrupt cancer cell growth and survival.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple tumor-related signaling pathways.